Literature DB >> 11773424

Comparison of gene transfer efficiencies and gene expression levels achieved with equine infectious anemia virus- and human immunodeficiency virus type 1-derived lentivirus vectors.

J P O'Rourke1, G C Newbound, D B Kohn, J C Olsen, B A Bunnell.   

Abstract

This report compares gene transfer efficiencies as well as durations and levels of gene expression for human immunodeficiency virus (HIV) and equine infectious anemia virus (EIAV) lentiviral vectors in a variety of human cell types in vitro. EIAV and HIV vectors transduced equivalent numbers of proliferating and G1/S- and G2/M-arrested cells, and both had very low efficiencies of transduction into G0-arrested cells. Analysis of the levels of both the enhanced green fluorescent protein (EGFP) and mRNA demonstrated that the HIV-transduced cells expressed greater levels of EGFP protein and RNA than the EIAV-transduced cells. Measurements of vector-derived EGFP RNA half-lives were fourfold higher with the HIV vector than with the EIAV vector. Long-term culture of EIAV-transduced human cells showed a significant decrease in the number of cells expressing the transgene; however, no corresponding loss was found in EIAV-transduced equine cells. In contrast, only a moderate decrease in the number of transgene-expressing cells was seen with the HIV vectors. Taken together, these results demonstrate that the EIAV vectors transduced human cells with efficiencies similar to those of the HIV vectors. However, our data indicate that transgene expression from EIAV vectors is limited by the instability of vector-derived RNA transcripts and silencing of the EIAV vectors over time.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11773424      PMCID: PMC135783          DOI: 10.1128/jvi.76.3.1510-1515.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  17 in total

1.  Gene transfer systems derived from Visna virus: analysis of virus production and infectivity.

Authors:  R D Berkowitz; H Ilves; I Plavec; G Veres
Journal:  Virology       Date:  2001-01-05       Impact factor: 3.616

2.  Human immunodeficiency virus type 2 lentiviral vectors: packaging signal and splice donor in expression and encapsidation.

Authors:  Jenice D'Costa; Heidi M Brown; Priya Kundra; Alberta Davis-Warren; Suresh K Arya
Journal:  J Gen Virol       Date:  2001-02       Impact factor: 3.891

3.  Gene silencing. Methylation meets acetylation.

Authors:  T H Bestor
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

4.  Rhesus monkey model for fetal gene transfer: studies with retroviral- based vector systems.

Authors:  A F Tarantal; J P O'Rourke; S S Case; G C Newbound; J Li; C I Lee; C R Baskin; D B Kohn; B A Bunnell
Journal:  Mol Ther       Date:  2001-02       Impact factor: 11.454

5.  Construction and molecular analysis of gene transfer systems derived from bovine immunodeficiency virus.

Authors:  R Berkowitz; H Ilves; W Y Lin; K Eckert; A Coward; S Tamaki; G Veres; I Plavec
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

6.  Functional correction of fanconi anemia group C hematopoietic cells by the use of a novel lentiviral vector.

Authors:  K Yamada; J C Olsen; M Patel; K W Rao; C E Walsh
Journal:  Mol Ther       Date:  2001-04       Impact factor: 11.454

7.  Novel bovine lentiviral vectors based on Jembrana disease virus.

Authors:  P Metharom; S Takyar; H H Xia; K A Ellem; J Macmillan; R W Shepherd; G E Wilcox; M Q Wei
Journal:  J Gene Med       Date:  2000 May-Jun       Impact factor: 4.565

8.  In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.

Authors:  L Naldini; U Blömer; P Gallay; D Ory; R Mulligan; F H Gage; I M Verma; D Trono
Journal:  Science       Date:  1996-04-12       Impact factor: 47.728

9.  Defective RNA packaging is responsible for low transduction efficiency of CAEV-based vectors.

Authors:  L Mselli-Lakhal; C Favier; M F Da Silva Teixeira; K Chettab; C Legras; C Ronfort; G Verdier; J F Mornex; Y Chebloune
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

10.  Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences.

Authors:  A Follenzi; L E Ailles; S Bakovic; M Geuna; L Naldini
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

View more
  19 in total

Review 1.  Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.

Authors:  Vincent Hurez; Robin D Hautton; James Oliver; R James Matthews; Casey K Weaver
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

2.  Mobilization and mechanism of transcription of integrated self-inactivating lentiviral vectors.

Authors:  Hideki Hanawa; Derek A Persons; Arthur W Nienhuis
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

3.  Effective transduction of primary mouse blood- and bone marrow-derived monocytes/macrophages by HIV-based defective lentiviral vectors.

Authors:  Lingbing Zeng; Shiming Yang; Chengxiang Wu; Linbai Ye; Yuanan Lu
Journal:  J Virol Methods       Date:  2006-01-20       Impact factor: 2.014

Review 4.  Gene Therapy for the Retinal Degeneration of Usher Syndrome Caused by Mutations in MYO7A.

Authors:  Vanda S Lopes; David S Williams
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-20       Impact factor: 6.915

5.  Characterization of the alpha interferon-induced postentry block to HIV-1 infection in primary human macrophages and T cells.

Authors:  Caroline Goujon; Michael H Malim
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

6.  The requirement for nucleoporin NUP153 during human immunodeficiency virus type 1 infection is determined by the viral capsid.

Authors:  Kenneth A Matreyek; Alan Engelman
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

7.  The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase.

Authors:  Lavanya Krishnan; Kenneth A Matreyek; Ilker Oztop; Kyeongeun Lee; Christopher H Tipper; Xiang Li; Mohd J Dar; Vineet N Kewalramani; Alan Engelman
Journal:  J Virol       Date:  2009-10-21       Impact factor: 5.103

8.  Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration.

Authors:  Aaron C Logan; Dennis L Haas; Tal Kafri; Donald B Kohn
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

9.  Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells).

Authors:  Joanna L Howarth; Youn Bok Lee; James B Uney
Journal:  Cell Biol Toxicol       Date:  2009-10-15       Impact factor: 6.691

10.  Transfer of the amino-terminal nuclear envelope targeting domain of human MX2 converts MX1 into an HIV-1 resistance factor.

Authors:  Caroline Goujon; Olivier Moncorgé; Hélène Bauby; Tomas Doyle; Wendy S Barclay; Michael H Malim
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.